Adding intranasal fluticasone to cefuroxime resolved acute rhinosinusitis

Willett, Laura R.
July 2002
ACP Journal Club;Jul/Aug2002, Vol. 137 Issue 1, p14
Academic Journal
Provides information on a study that examined whether the addition of intranasal fluticasone to cefuroxime more effective than the addition of placebo for prompting recovery in patients with acute rhinosinusitis and a history of chronic or recurrent sinus symptoms. Study design and setting; Main outcome measures; Main results; Conclusion.


Related Articles

  • Mometasone furoate nasal spray was more effective for symptom relief of acute rhinosinusitis than amoxicillin or placebo.  // Evidence Based Medicine;Aug2006, Vol. 11 Issue 4, p114 

    The article presents information on a research to find the relative effectiveness of mometasone furoate nasal spray, amoxicillin and placebo in patients with acute, uncomplicated rhinosinusitis. The randomised controlled design was chosen for the research. The research found that twice daily...

  • Do intranasal corticosteroids aid treatment of acute sinusitis in patients with a history of recurrent sinus symptoms? (Poem). Winn, Robert J. // Journal of Family Practice;Apr2002, Vol. 51 Issue 4, p386 

    The article discusses research being done on the benefit of the addition of fluticasone, an intranasal corticosteroid, to cefurixome in treating acute sinusitis in patients with a history of recurrent sinus symptoms. It references a study by R. J. Dolor et al published in the 2001 issue of the...

  • Mometasone furoate nasal spray was more effective for symptom relief of acute rhinosinusitis than amoxicillin or placebo. Meltzer, E. O.; Bachert, C.; Staudinger, H. // Archives of Disease in Childhood;Dec2006 Supplement, Vol. 91, p124 

    The article presents a study on the effectiveness of mometasone furoate nasal spray than amoxicillin or placebo for symptom relief in patients with acute rhinosinusitis. During the treatment phase, twice a day mometasone resulted in better mean and improved total symptom scores than amoxicillin...

  • Antibiotics no Better than Placebo against Acute Rhinosinusitis. Deresinski, Stan // Infectious Disease Alert;Mar2012, Vol. 31 Issue 6, p66 

    Garbutt and colleagues performed a randomized placebo controlled trial designed to evaluate the efficacy of antibiotic therapy in patients with a clinical diagnosis of acute rhinosinusitis at 10 primary care practices in St. Louis. The diagnosis required a history of maxillary pain or tenderness...

  • A prospective, double-blind, randomized study on the use of a topical anesthetic, vasoconstrictor... Leder, Steven B.; Ross, Douglas A.; Briskin, Kenneth B.; Sasaki, Clarence T. // Journal of Speech, Language & Hearing Research;Dec1997, Vol. 40 Issue 6, p1352 

    Compares patient comfort levels following administration of a topical anesthetic, vasoconstrictor, placebo, or nothing to the nasal mucosa prior to flexible fiberoptic transnasal endoscopy. Differences on patient comfort levels during flexible fiberoptic nasendoscopy; Deleterious side effects...

  • Randomised double blind controlled clinical trial of intranasal budesonide in treatment of hay fever. Cameron, A.W.; Stanley, I.M.; Wright, H.J. // British Medical Journal (Clinical Research Edition);6/23/1984, Vol. 288 Issue 6434, p1881 

    Examines the effectiveness of intranasal budesonide in treating hay fever. Supply of antithiamine tablets to patients; Conduction of a clinical trial on budesonide; Comparison between the therapeutic uses of intranasal budesonide and placebo.

  • ON-TARGET NASAL SPRAYS. Moll, Steven W. // Cortlandt Forum;5/25/2004, Vol. 17 Issue 5, p82 

    Presents on the efficacy of nasal sprays for sinusitis in the U.S.

  • Antibiotics no Better than Placebo Against Acute Rhinosinusitis. Deresinski, Stan // Internal Medicine Alert;4/29/2012, Vol. 34 Issue 8, p57 

    This article originally appeared in the March issue of Infectious Disease Alert. At that time it was peer reviewed by Timothy Jenkins, MD, Assistant Professor of Medicine, University of Colorado, Denver Health Medical Center. Dr. Jenkins reports no financial relationships relevant to this field...

  • Onset of action of ciclesonide once daily in the treatment of seasonal allergic rhinitis. Patel, Piyush; Patel, Deepen; Kunjibettu, Sudeesha; Hall, Nancy; Wingertzahn, Mark A. // ENT: Ear, Nose & Throat Journal;Jun2008, Vol. 87 Issue 6, p340 

    Ciclesonide is an intranasal corticosteroid approved for the treatment of allergic rhinitis. We conducted a randomized, double-blind, parallel-group, placebo-controlled study to evaluate the time to onset of action of ciclesonide 200 µg once daily in 502 adults with seasonal allergic rhinitis...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics